Full text

Turn on search term navigation

© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Reverse transcription polymerase chain reaction (RT-PCR) is an important tool for the detection of target RNA molecules and the assay of RNA pathogens. Coupled RT-PCR is performed with an enzyme mixture containing a reverse transcriptase and a thermostable DNA polymerase. To date, several biotechnological companies offer artificial thermostable DNA polymerases with a built-in reverse transcriptase activity for use in the coupled RT-PCR instead of the enzyme mixtures. Here, we compared the artificial DNA polymerases and conventional enzyme mixtures for the RT-PCR by performing end-point and real-time RT-PCR assays using severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV2) RNA and endogenous mRNA molecules as templates. We found that the artificial enzymes were suitable for different RT-PCR applications, including SARS-CoV2 RNA detection but not for long-fragment RT-PCR amplification.

Details

Title
Comparison of Commercially Available Thermostable DNA Polymerases with Reverse Transcriptase Activity in Coupled Reverse Transcription Polymerase Chain Reaction Assays
Author
Smirnova, Evgeniya V 1   VIAFID ORCID Logo  ; Blagodatskikh, Konstantin A 2   VIAFID ORCID Logo  ; Barsova, Ekaterina V 3 ; Varlamov, Dmitriy A 4 ; Kramarov, Vladimir M 5 ; Ignatov, Konstantin B 5   VIAFID ORCID Logo 

 Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia; [email protected] (E.V.S.); [email protected] (E.V.B.) 
 Laboratory of Molecular Oncology, Pirogov Russian National Research Medical University, 117513 Moscow, Russia; [email protected]; The Center of Genetics and Reproductive Medicine “Genetico” PJSC, 119333 Moscow, Russia 
 Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia; [email protected] (E.V.S.); [email protected] (E.V.B.); Institute of Translational Medicine, Pirogov Russian National Research Medical University, 117513 Moscow, Russia 
 Syntol JSC, 127550 Moscow, Russia; [email protected] 
 Vavilov Institute of General Genetics, Russian Academy of Sciences, 119991 Moscow, Russia; [email protected] 
First page
11
Publication year
2025
Publication date
2025
Publisher
MDPI AG
e-ISSN
24099279
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3171127574
Copyright
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.